Novartis AG
TREM2 MUTANTS RESISTANT TO SHEDDASE CLEAVAGE
Last updated:
Abstract:
Provided herein are methods and compositions related to TREM2 mutants resistant to sheddase cleavage, e.g., human TREM2 mutants resistant to sheddase cleavage, and nucleic acids encoding such TREM2 mutants resistant to sheddase cleavage.
Status:
Application
Type:
Utility
Filling date:
26 Jul 2018
Issue date:
2 Jul 2020